Chronic Obstructive Pulmonary Disease in UK Primary Care: Incidence and Risk Factors

被引:34
作者
Garcia Rodriguez, Luis A. [1 ]
Wallander, Mari-Ann [2 ]
Barreales Tolosa, Laura [1 ]
Johansson, Saga [3 ,4 ]
机构
[1] Spanish Ctr Pharmacoepidemiol Res CEIFE, Madrid 28004, Spain
[2] Uppsala Univ, Dept Publ Hlth & Caring Sci, S-75183 Uppsala, Sweden
[3] AstraZeneca R&D, S-43183 Molndal, Sweden
[4] Gothenburg Univ, Sahlgrenska Acad, Inst Med, SE-40530 Gothenburg, Sweden
关键词
COPD; Epidemiology; UK; Incidence; PRACTICE RESEARCH DATABASE; PHYSICIAN-DIAGNOSED COPD; ANTIINFLAMMATORY ROLE; NUTRITIONAL-STATUS; FOLLOW-UP; MORTALITY; INFLAMMATION; ASSOCIATION; SIMVASTATIN; EPIDEMIOLOGY;
D O I
10.1080/15412550903156325
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
We evaluated the association of chronic obstructive pulmonary disease (COPD) with modifiable risk factors such as smoking and prescription medications, and investigated possible risk factors unique to patients who had never smoked. The UK General Practice Research Database was used to identify a cohort of patients with a first diagnosis of COPD (n = 1927) along with age- and sex-matched controls without COPD (n = 16 546). The incidence of COPD diagnoses and the risks associated with medication use, co-morbidities, and demographic factors, were estimated. The incidence of COPD was 2.6 per 1000 person-years (95% confidence interval [CI]: 2.5-2.7) among 40-89 year-olds. The risk significantly increased in current and former smokers (OR: 6.15 [95% CI: 5.41-7.00] and 3.45 [95% CI: 2.96-4.02]), respectively. The risk was significantly lower in former smokers than current smokers (OR: 0.61; 95% CI: 0.52-0.71). Current statin use was significantly associated with a reduced risk (OR: 0.45; 95% CI: 0.25-0.80). In never smokers, risk factors included advanced age and obesity. The risk in never smokers was more strongly related to paracetamol use (OR: 1.82; 95% CI: 1.33-2.49) than in current and former smokers (OR: 1.48; 95% CI: 1.18-1.86). In summary, COPD is associated with a range of cardiovascular and respiratory conditions and the risk is influenced by current and past medications. While the risk factors are similar in smokers and never smokers, some were unique to never smokers. Moreover, subjects who stopped smoking had a substantially lower COPD risk than those who continued smoking.
引用
收藏
页码:369 / 379
页数:11
相关论文
共 44 条
[1]  
[Anonymous], 2016, Fact Sheet
[2]   Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-α release [J].
Churg, A ;
Wang, RD ;
Tai, H ;
Wang, XS ;
Xie, CS ;
Dai, J ;
Shapiro, SD ;
Wright, JL .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (08) :1083-1089
[3]   ABC of chronic obstructive pulmonary disease - Definition, epidemiology, and risk factors [J].
Devereux, Graham .
BRITISH MEDICAL JOURNAL, 2006, 332 (7550) :1142-1144
[4]   Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview [J].
Di Stefano, A ;
Caramori, G ;
Ricciardolo, FLM ;
Capelli, A ;
Adcock, IM ;
Donner, CF .
CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (08) :1156-1167
[5]   TUMOR-NECROSIS-FACTOR-ALPHA LEVELS AND WEIGHT-LOSS IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
DIFRANCIA, M ;
BARBIER, D ;
MEGE, JL ;
OREHEK, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (05) :1453-1455
[6]  
Frank Timothy L, 2007, Prim Care Respir J, V16, P169, DOI 10.3132/pcrj.2007.00028
[7]   Obesity and the lung: 5 . Obesity and COPD [J].
Franssen, F. M. E. ;
O'Donnell, D. E. ;
Goossens, G. H. ;
Blaak, E. E. ;
Schols, A. M. W. J. .
THORAX, 2008, 63 (12) :1110-1117
[8]   Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins [J].
Frost, Floyd J. ;
Petersen, Hans ;
Tollestrup, Kristine ;
Skipper, Betty .
CHEST, 2007, 131 (04) :1006-1012
[9]   Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis [J].
Gan, WQ ;
Man, SFP ;
Senthilselvan, A ;
Sin, DD .
THORAX, 2004, 59 (07) :574-580
[10]   Nutritional status and mortality in chronic obstructive pulmonary disease [J].
GrayDonald, K ;
Gibbons, L ;
Shapiro, SH ;
Macklem, PT ;
Martin, JG .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (03) :961-966